By using thyroid‐specific markers such as thyroglobulin and TTF‐1, IHC helps confirm the presence of thyroid tissue within ovarian tumors, distinguishing MSO from other ovarian neoplasms [12, 23, 24]. Here, TTF1 is linked to thyroid gland disorder.